{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:39:42Z","timestamp":1790167182352,"version":"4.1.0"},"reference-count":90,"publisher":"Informa UK Limited","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.2217\/pgs.12.78","type":"journal-article","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T07:23:56Z","timestamp":1343460236000},"page":"1055-1071","source":"Crossref","is-referenced-by-count":25,"title":["Functional Impact and Prevalence of Polymorphisms Involved in the Hepatic Glucuronidation of Valproic Acid"],"prefix":"10.1080","volume":"13","author":[{"given":"Dimitrios","family":"Chatzistefanidis","sequence":"first","affiliation":[{"name":"Department of Neurology, Medical School, University of Ioannina, Ioannina, Greece"},{"name":"Medical Genetics & Assisted Reproduction, Medical School, University of Ioannina, Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Georgiou","sequence":"additional","affiliation":[{"name":"Medical Genetics & Assisted Reproduction, Medical School, University of Ioannina, Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanassios P","family":"Kyritsis","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical School, University of Ioannina, Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Markoula","sequence":"additional","affiliation":[{"name":"Department of Neurology, Medical School, University of Ioannina, Ioannina, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2012,7,27]]},"reference":[{"key":"e_1_3_3_3_1_1","first-page":"435","volume":"18","author":"Meunier H","year":"1963","unstructured":"Meunier H , CarrazG, MeunierY, EymardP, AimardM. [Pharmacodynamic properties of N-dipropylacetic acid]. Therapie18 , 435\u2013438 (1963).","journal-title":"Therapie"},{"key":"e_1_3_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1248\/yakushi1947.92.7_896"},{"key":"e_1_3_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/bms.1200010415"},{"key":"e_1_3_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/bms.1200030509"},{"issue":"5","key":"e_1_3_3_3_5_1","first-page":"1090","volume":"27","author":"Kochen W","year":"1977","unstructured":"Kochen W , ImbeckH, JakobsC. Studies on the urinary excretion of metabolites of valproic acid (dipropylacetic acid) in rats and humans. Arzneimittelforschung27(5) , 1090\u20131099 (1977).","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"e_1_3_3_3_6_1","first-page":"657","volume":"28","author":"Sch\u00e4fer H","year":"1978","unstructured":"Sch\u00e4fer H , L\u00fchrsR. Metabolite pattern of valproic acid. Part I: gaschromatographic determination of the valproic acid metabolite artifacts, heptanone-3, 4- and 5-hydroxyvalproic acid lactone. Arzneimittelforschung.28(4) , 657\u2013662 (1978).","journal-title":"Arzneimittelforschung."},{"issue":"8","key":"e_1_3_3_3_7_1","first-page":"912","volume":"28","author":"Wong H","year":"2000","unstructured":"Wong H , KumarS, RurakDW, KwanE, AbbottFS, RiggsKW. Ontogeny of valproic acid disposition and metabolism: a developmental study in postnatal lambs and adult sheep. Drug Metab. Dispos.28(8) , 912\u2013919 (2000).","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"e_1_3_3_3_8_1","first-page":"857","volume":"28","author":"Kumar S","year":"2000","unstructured":"Kumar S , WongH, YeungSA, RiggsKW, AbbottFS, RurakDW. Disposition of valproic acid in maternal fetal, and newborn sheep. II: metabolism and renal elimination. Drug Metab. Dispos.28(7) , 857\u2013864 (2000).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_9_1","unstructured":"Ionescu C CairaMR. Pathways of biotransformation \u2013 phase II reactions. In: Drug Metabolism: Current Concepts. Springer Dodrecht The Netherlands 129\u2013134 (2005)."},{"key":"e_1_3_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2011.10.002"},{"key":"e_1_3_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)50724-4"},{"key":"e_1_3_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)35280-8"},{"key":"e_1_3_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.22.8381"},{"key":"e_1_3_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200106000-00011"},{"key":"e_1_3_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000173483.13689.56"},{"key":"e_1_3_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200004000-00006"},{"key":"e_1_3_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1006\/abbi.2001.2383"},{"issue":"1","key":"e_1_3_3_3_18_1","first-page":"50","volume":"20","author":"Ebner T","year":"1993","unstructured":"Ebner T , BurchellB. Substrate specificities of two stably expressed human liver UDP-glucuronosyl transferases of the UGT1 gene family. Drug Metab. Dispos.20(1) , 50\u201355 (1993).","journal-title":"Drug Metab. Dispos."},{"issue":"1","key":"e_1_3_3_3_19_1","first-page":"475","volume":"264","author":"Jin C","year":"1993","unstructured":"Jin C , MinersJO, LillywhiteKJ, MackenziePI. Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid containing drugs. J. Pharm. Exp. Ther.264(1) , 475\u2013479 (1993).","journal-title":"J. Pharm. Exp. Ther."},{"key":"e_1_3_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2004.02.004"},{"key":"e_1_3_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.022426"},{"key":"e_1_3_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.027227"},{"issue":"10","key":"e_1_3_3_3_23_1","first-page":"1165","volume":"27","author":"Cheng Z","year":"1999","unstructured":"Cheng Z , Radominska-PandyaA, TephlyTR. Studies on the substrate specificity of human intestinal UDP-lucuronosyltransferases 1A8 and 1A10. Drug Metab. Dispos.27(10) , 1165\u20131170 (1999).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.1.133"},{"key":"e_1_3_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000114771.78957.cb"},{"key":"e_1_3_3_3_26_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.09.21"},{"key":"e_1_3_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-199712000-00007"},{"key":"e_1_3_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00306-9"},{"key":"e_1_3_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.081950"},{"key":"e_1_3_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.104.081968"},{"issue":"29","key":"e_1_3_3_3_31_1","first-page":"2033","volume":"87","author":"Sun YP","year":"2007","unstructured":"Sun YP , TanL, WangY, SongJH. Effect of UGT1A6 genetic polymorphisms on the metabolism of sodium valproate. Zhonghua Yi Xue Za Zhi87(29) , 2033\u20132035 (2007).","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"6","key":"e_1_3_3_3_32_1","first-page":"429","volume":"12","author":"Wang Y","year":"2010","unstructured":"Wang Y , GaoL, LiuYP, HuangNN, XuSJ, MaDJ. Effect of UGTIA6 A541G genetic polymorphism on the metabolism of valproic acid in Han epileptic children from Henan. Zhongguo. Dang Dai. Er. Ke. Za. Zhi.12(6) , 429\u2013432 (2010).","journal-title":"Zhongguo. Dang Dai. Er. Ke. Za. Zhi."},{"key":"e_1_3_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228"},{"key":"e_1_3_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.11.64"},{"key":"e_1_3_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.DMPK-11-RG-144"},{"key":"e_1_3_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.20.85"},{"key":"e_1_3_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)02073-R"},{"issue":"1","key":"e_1_3_3_3_38_1","first-page":"73","volume":"26","author":"Coffman BL","year":"1998","unstructured":"Coffman BL , KingCD, RiosGR, TephlyTR. The glucuronidation of opioids, other xenobiotics, and androgens by human UGT2B7Y(268) and UGT2B7H(268). Drug Metab. Dispos.26(1) , 73\u201377 (1998).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200011000-00002"},{"key":"e_1_3_3_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(03)00076-5"},{"key":"e_1_3_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100324"},{"key":"e_1_3_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.tpj.6500139"},{"key":"e_1_3_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.9.1125"},{"key":"e_1_3_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00053-5"},{"issue":"5","key":"e_1_3_3_3_45_1","first-page":"497","article-title":"3\u00b4-azido-3\u00b4-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7).","volume":"28","author":"Barbier O","year":"2000","unstructured":"Barbier O , TurgeonD, GirardC et al. 3\u00b4-azido-3\u00b4-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7). Drug Metab. Dispos. 28(5) , 497\u2013502 (2000).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.001651"},{"key":"e_1_3_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.010553"},{"key":"e_1_3_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-006-0248-2"},{"key":"e_1_3_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100073"},{"key":"e_1_3_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr818"},{"key":"e_1_3_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0530"},{"key":"e_1_3_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2857"},{"key":"e_1_3_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3708"},{"key":"e_1_3_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.08.004"},{"issue":"1","key":"e_1_3_3_3_55_1","first-page":"101","article-title":"Contribution of polymorphisms in UDP-glucuronosyltransferase and CYP2D6 to the individual variation in disposition of carvedilol.","volume":"9","author":"Takekuma Y","year":"2006","unstructured":"Takekuma Y , TakenakaT, KiyokawaM et al. Contribution of polymorphisms in UDP-glucuronosyltransferase and CYP2D6 to the individual variation in disposition of carvedilol. J. Pharm. Pharm. Sci. 9(1) , 101\u2013112 (2006).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"e_1_3_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.30.537"},{"key":"e_1_3_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.5.677"},{"key":"e_1_3_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.22.382"},{"issue":"9","key":"e_1_3_3_3_59_1","first-page":"1048","article-title":"Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population.","volume":"32","author":"Saeki M","year":"2004","unstructured":"Saeki M , SaitoY, JinnoH et al. Single nucleotide polymorphisms and haplotype frequencies of UGT2B4 and UGT2B7 in a Japanese population. Drug Metab. Dispos. 32(9) , 1048\u20131054 (2004).","journal-title":"Drug Metab. Dispos."},{"issue":"3","key":"e_1_3_3_3_60_1","first-page":"329","volume":"9","author":"Lampe JW","year":"2000","unstructured":"Lampe JW , BiglerJ, BushAC, PotterJD. Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y). Cancer Epidemiol. Biomarkers Prev.9(3) , 329\u2013333 (2000).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"e_1_3_3_3_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-006-0206-z"},{"key":"e_1_3_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2006.01.002"},{"key":"e_1_3_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.DMPK-10-SC-021"},{"key":"e_1_3_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1996.1251"},{"issue":"6","key":"e_1_3_3_3_65_1","first-page":"507","volume":"26","author":"Green MD","year":"1998","unstructured":"Green MD , KingCD, MojarrabiB, MackenziePI, TephlyTR. Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab. Dispos.26(6) , 507\u2013512 (1998).","journal-title":"Drug Metab. Dispos."},{"key":"e_1_3_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-003-0119-y"},{"key":"e_1_3_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.106.009761"},{"key":"e_1_3_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32806d87a4"},{"key":"e_1_3_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e3283489ce2"},{"key":"e_1_3_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20131"},{"key":"e_1_3_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-3219"},{"key":"e_1_3_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.002576"},{"key":"e_1_3_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/bcr1539"},{"key":"e_1_3_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0783-8"},{"key":"e_1_3_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2011.01.016"},{"key":"e_1_3_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e328348c76b"},{"key":"e_1_3_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.20.144"},{"key":"e_1_3_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.054072"},{"key":"e_1_3_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.32.8.775"},{"key":"e_1_3_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2857"},{"key":"e_1_3_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.08.004"},{"key":"e_1_3_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.051250"},{"key":"e_1_3_3_3_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2008.00247.x"},{"key":"e_1_3_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.24.482"},{"key":"e_1_3_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.108.024596"},{"key":"e_1_3_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004267159"},{"key":"e_1_3_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.18.146"},{"key":"e_1_3_3_4_2_1","unstructured":"Flinders University UDP Glucuronosyltransferase Homepage www.flinders.edu.au\/medicine\/sites\/clinical-pharmacology\/ugt-homepage.cfm (Accessed 2May2012)"},{"key":"e_1_3_3_4_3_1","unstructured":"Laval University Pharmacogenomics Laboratory www.pharmacogenomics.pha.ulaval.ca\/cms\/ugt_alleles (Accessed 20December2011)"},{"key":"e_1_3_3_4_4_1","unstructured":"dbSNP NCBI www.ncbi.nlm.nih.gov\/projects\/SNP"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs.12.78","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T19:29:22Z","timestamp":1715974162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs.12.78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.2217\/pgs.12.78"],"URL":"https:\/\/doi.org\/10.2217\/pgs.12.78","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}